Skip to main content
. Author manuscript; available in PMC: 2009 Dec 18.
Published in final edited form as: Retina. 2008 Jul–Aug;28(7):919–930. doi: 10.1097/IAE.0b013e31818144a7

Table 1. Study eye major inclusion and exclusion criteria.

Inclusion criteria
  • Best corrected E-ETDRS visual acuity letter score of ≤73 (approximate Snellen equivalent of 20/40 or worse) and ≥24 (approximate Snellen equivalent of 20/320 or better). [Note: the original upper limit of visual acuity letter score was expanded from68 letters to73 letters eight months after accrual began]

  • Center-involved diabetic macular edema present on clinical examination

  • Central subfield mean thickness (CST) of two OCT fast macular scans ≥250 microns

  • Media clarity, pupillary dilation, and subject cooperation sufficient for adequate fundus photographs

Exclusion criteria
  • Presence of macular edema due to a cause other than diabetic macular edema

  • Presence of an ocular condition such that visual acuity would not improve from resolution of the edema (e.g. foveal atrophy)

  • Substantial cataract estimated to have reduced visual acuity by 3 lines or more

  • Prior treatment with intravitreal corticosteroids at any time or peribulbar steroid injection within 6 months prior to randomization

  • History of focal/grid macular photocoagulation within 15 weeks (3.5 months) or panretinal photocoagulation (PRP) within 4 months prior to randomization or anticipated need for PRP within the 4 months following randomization

  • Prior pars plana vitrectomy

  • Major ocular surgery (including cataract extraction) within prior 6 months or anticipated within the next 6 months following randomization

  • YAG capsulotomy performed within 2 months prior to randomization

  • Intraocular pressure (IOP) ≥25 mmHg, open-angle glaucoma (either primary open-angle glaucoma or other cause of open-angle glaucoma), steroid-induced IOP elevation that required IOP-lowering treatment or pseudoexfoliation

  • Aphakia